To support future innovation in healthcare, we are actively seeking new partnerships to develop animal-derived APIs, ingredients and compounds, including glycosaminoglycans, proteins and bioactive peptides of non-recombinant origin, complex lipids and other high-value biological substances. Together, we can kickstart the next exciting development in the pharmaceutical space.